An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis
NCT00619866 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 155
Last updated 2018-09-07
Summary
This study is designed to see how elagolix works compared to placebo in women with endometriosis and to see the effect, if any, on bone mineral density.
Conditions
- Endometriosis, Pain
Interventions
- DRUG
-
Elagolix
Elagolix tablets administered orally
- DRUG
-
Placebo tablet administered orally
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AbbVie Inc. · AbbVie
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-19
- Primary Completion
- 2009-04-20
- Completion
- 2009-08-28
- FDA Drug
- Yes
More Related Trials
-
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain
NCT01760954 ·Status: COMPLETED ·Phase: PHASE3
-
Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain
NCT02143713 ·Status: COMPLETED ·Phase: PHASE3
-
Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
NCT00437658 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
NCT06076486 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
NCT04333576 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
NCT03343067 ·Status: TERMINATED ·Phase: PHASE3
-
Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain
NCT04630990 ·Status: COMPLETED
-
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
NCT03213457 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
NCT01441635 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada
NCT04080856 ·Status: COMPLETED
-
Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.
NCT03992846 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
NCT04614246 ·Status: TERMINATED ·Phase: PHASE2
-
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
NCT04372121 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain
NCT03986944 ·Status: TERMINATED ·Phase: PHASE3
-
Cardiovascular Disease Risk in Women With Endometriosis
NCT03746535 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
NCT03886220 ·Status: COMPLETED ·Phase: PHASE4
-
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
NCT07100782 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
NCT01817530 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
NCT00001848 ·Status: COMPLETED ·Phase: PHASE2
-
Endometriosis Trial: Study of NBI-56418 in Endometriosis
NCT00109512 ·Status: COMPLETED ·Phase: PHASE2
-
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
NCT06279195 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
NCT05560646 ·Status: COMPLETED ·Phase: PHASE2
-
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
NCT04335591 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
NCT00556075 ·Status: TERMINATED ·Phase: PHASE2
-
Somatic Stem Cells in Endometriosis
NCT01412138 ·Status: UNKNOWN